Science Current Events | Science News | Brightsurf.com
 

Extra-aggressive form of idiopathic pulmonary fibrosis identified

May 30, 2007

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disorder from which most patients die within 5 years after diagnosis. The disease is characterized by the insidious onset of dyspnea or cough and usually evolves slowly.

Now, Selman and coworkers present in an article published in the online, open-access journal PLoS ONE on Wednesday 30th May, strong evidence indicating that a subset of IPF patients has a short duration of symptoms before diagnosis and display an accelerated clinical course to end-stage disease. The authors postulate that these "rapid progressor" patients, predominantly smoking males, represent a distinct clinical phenotype compared with the usual "slow progressors" patients.

"These findings highlight the variability in the progression and outcome of IPF, and may explain, in part, the difficulty in obtaining significant and reproducible results in studies of therapeutic interventions in patients with IPF," said Dr Selman, who is the Director of Research at the National Institute of Respiratory Research in Mexico City and the lead author on this publication. "They also suggest that physicians should pay more attention to the time of onset of symptoms, and to look for other signs that allow the identification of these rapid progressor patients".

In this study the authors performed global gene expression analysis and other molecular studies in a subset of patients and identified a number of genes that were differentially expressed in both groups, suggesting that rapid progressors are biologically distinct from slow progressors.

"While preliminary, these results may allow investigators to identify biomarkers of disease progression," said Dr King, who is the Chief of Medicine at San Francisco General Hospital and an internationally renowned expert in research and management of pulmonary fibrosis.

The senior author on this paper, Dr Naftali Kaminski, who is the Director of the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh, added that this research highlighted the need to collect as much information on patients with IPF as possible. "We are only now starting to really understand the disease and characterize it," he said, "therefore, it is critical for patients with the disease to be seen in centers that are actively involved in IPF research."

Better identification and understanding of these differences may provide insights into the pathogenesis of IPF and assist in the development of therapeutic interventions for this devastating lung disease.

Public Library of Science


Related Pulmonary Fibrosis Current Events and Pulmonary Fibrosis News Articles


UA College of Pharmacy faculty member develops inhalers to treat lung diseases
Heidi M. Mansour, PhD, assistant professor in the University of Arizona College of Pharmacy, is working to develop advanced dry powder inhalers to treat and prevent pulmonary diseases.

New paste prevents scarring caused by radiation therapy for cancer
An antiscarring paste when applied to the skin of mice halts fibrosis caused by the radiation used in cancer therapy.

Air pollution and traffic linked to deaths and organ rejection in lung transplant patients
Researchers have shown for the first time that lung transplant patients in Europe who live on or near busy roads with high levels of air pollution are more likely to die or to experience chronic organ rejection, than those living in less polluted areas.

Increased protein turnover contributes to the development of pulmonary fibrosis
Idiopathic pulmonary fibrosis is a very aggressive form of pulmonary fibrosis and has a particularly poor prognosis.

Rapid skin improvement seen after treating systemic sclerosis patients with fresolimumab
A major treatment breakthrough for total body scarring of the skin that occurs in patients with systemic sclerosis (SSc), also known as scleroderma, may soon be available for the estimated 300,000 Americans who suffer with this condition.

Study provides insights on chronic lung disease
A new study shows that shorter telomeres--which are the protective caps at the end of a cell's chromosomes--are linked with worse survival in a progressive respiratory disease called idiopathic pulmonary fibrosis (IPF).

UGA researchers find potential treatment for fatal lung diseases
Researchers at the University of Georgia have discovered that the drug triciribine may reverse or halt the progression of pulmonary fibrosis and pulmonary hypertension, two respiratory diseases that are almost invariably fatal.

New approach for treating idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease for which as yet no causal therapy exists. It is, however, known that the lung interstitium - the connective tissue between the air sacs in the lower part of the lung - is affected.

Mutations in 2 genes linked to familial pulmonary fibrosis and telomere shortening
Researchers at UT Southwestern Medical Center have identified mutations in two genes that cause a fatal lung scarring disease known as familial pulmonary fibrosis.

New method enables drug target validation for COPD treatment
Together with clinical partners, a team led by Dr. Dr. Melanie Königshoff and the doctoral student Franziska Uhl at the Comprehensive Pneumology Center of Helmholtz Zentrum München have investigated, for the first time, the suitability of Wnt/beta-catenin.
More Pulmonary Fibrosis Current Events and Pulmonary Fibrosis News Articles

Pulmonary Fibrosis: Coping With a Terminal Disease

Pulmonary Fibrosis: Coping With a Terminal Disease
by Lifestyle Design Solutions


Pulmonary Fibrosis: Coping With a Terminal Disease by Robert Post

What do you do when you learn you have Pulmonary Fibrosis, a terminal disease for which there is presently no cure? The author relates his personal experience and explains how he has learned to cope with the disease, products and methods he uses for maintaining health and combating progression of the disease and explains how you can, too.

A linked resources section gives advice on finding and using support groups and Pulmonary Rehabilitation programs. Products and sources are identified that the author has found to be beneficial or vital for health maintenance.

This publication contains frank material that some may find disturbing to read but the author feels the patient and their caregiver...

Journey of the CareGiver: Battling Pulmonary Fibrosis

Journey of the CareGiver: Battling Pulmonary Fibrosis
by MS, Lois Moody RN (Author)


The latest edition of this book (Surviving Caregiving) is available for the same price at: www.amazon.com/Surviving-Caregiving-Challenges-Lois-Moody/dp/1501029878/ref=sr_1_4?ie=UTF8&qid=1410298234&sr=8-4&keywords=surviving+caregiving

Breathing Should Never Be Hard Work: One Man's Journey with Idiopathic Pulmonary Fibrosis

Breathing Should Never Be Hard Work: One Man's Journey with Idiopathic Pulmonary Fibrosis
by Robert Davidson (Author)


Robert Davidson was diagnosed with Idiopathic Pulmonary Fibrosis in October 2007 after having difficulties with the fitness test necessary to retain senior level soccer referee status. Rather than give in to the disease and die, he decided to fight and live as normal a life as possible, borrowing from Winston Churchill, the mantra "Never surrender". He and his wife, Heather, believe it was this attitude that led to him "winning" a double lung transplant January 30, 2010, just weeks before he would have died from the disease. This book is about his journey with that life threatening disease. Although it "steals away the sufferer's breath" Robert travelled to China (finding 12,800 feet up the Himalayas too high) and to the highlands of Scotland for his wife's 60th birthday celebration. ...

The Best Cure for Idiopathic Pulmonary Fibrosis with Natural Remedies

The Best Cure for Idiopathic Pulmonary Fibrosis with Natural Remedies


This is the complete and most comprehensive guide on treating and controlling idiopathic pulmonary fibrosis.

The eBook extensively deals with causes, signs and symptoms of for lung fibrosis, survival possibilities of those with pulmonary fibrosis, the complete procedure for lung transplantation, different types of pulmonary fibrosis and the best treatment options for restoring the lungs' functions quickly.

Every aspect of for pulmonary fibrosis has been discussed in pure layman's terms for a better understanding.

I have written the eBook covering all the aspects of pulmonary fibrosis and accompanying physical and mental distress in a simple language with a view to help everyone understand the problem and get it treated in an appropriate manner.
The Official Patient's Sourcebook on Idiopathic Pulmonary Fibrosis

The Official Patient's Sourcebook on Idiopathic Pulmonary Fibrosis
by James N. Parker (Author)


This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to idiopathic pulmonary fibrosis (also alveolocapillary block; cryptogenic fibrosing alveolitis; diffuse fibrosing alveolitis; fibrosing alveolitis; Hamman-Rich syndrome; idiopathic diffuse interstitial pulmonary fibrosis), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various...

Improving Lung Health in 30 Days: Pulmonary Rehabilitation Plan for COPD, Emphysema, Fibrosis, Bronchiectasis and More

Improving Lung Health in 30 Days: Pulmonary Rehabilitation Plan for COPD, Emphysema, Fibrosis, Bronchiectasis and More
by Robert Redfern (Author)


Improving Lung Health in 30 Days includes a rehabilitation plan to recover lung health and improve pulmonary conditions such as bronchitis, bronchiectasis, COPD, cystic fibrosis and emphysema amongst others.

Improving Fibrosis in 30 Days

Improving Fibrosis in 30 Days
by Naturally Healthy Publications


Improving Fibrosis in 30 Days includes a rehabilitation plan to improve your pulmonary fibrosis symptoms and to attain long term health.

Why do patients get idiopathic pulmonary fibrosis? Current concepts in the pathogenesis of pulmonary fibrosis

Why do patients get idiopathic pulmonary fibrosis? Current concepts in the pathogenesis of pulmonary fibrosis


Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease of unknown origin. Recent findings suggest that IPF results from multiple factors that eventually lead to interstitial lung injury. In the pathogenesis it is likely that complex relationships between genetic predispositions, environmental exposures, and lung infections promote the fibrotic processes causing IPF; it is this complexity and the multiplicity of causes that make the population and clinical course of IPF so heterogeneous. Thus, it is clear that one common factor driving IPF pathogenesis in all patients would be far too simplified of an understanding. In recent years, efforts have been made in finding therapeutic strategies that target disease progression rather than disease onset. The biochemical composition and...

Saunders Comprehensive Review for the NCLEX-RN® Examination, 6e (Saunders Comprehensive Review for Nclex-Rn)

Saunders Comprehensive Review for the NCLEX-RN® Examination, 6e (Saunders Comprehensive Review for Nclex-Rn)
by Linda Anne Silvestri PhD RN (Author)


Often called the ‘the best NCLEX® exam review book ever,’ Saunders Comprehensive Review for the NCLEX-RN® Examination provides everything you need to prepare for the NCLEX exam - complete content review and over 5,100 NCLEX examination-style questions in the book and online. Don't make the mistake of assuming the quality of the questions is the same in all NCLEX exam review books, because only this book includes the kind of questions that consistently test the critical thinking skills necessary to pass today's NCLEX exam. Even better, all answers include detailed rationales to help you learn from your answer choices, as well as test-taking strategies with tips on how to best approach each question. Written by the most trusted name in NCLEX review, Linda Anne Silvestri, and updated...

Pulmonary Pathophysiology: The Essentials (PULMONARY PATHOPHYSIOLOGY (WEST))

Pulmonary Pathophysiology: The Essentials (PULMONARY PATHOPHYSIOLOGY (WEST))
by John B. West MD PhD (Author)


This companion monograph to West's Respiratory Physiology covers normal respiratory function and focuses on the function of the diseased lung. Pulmonary Pathophysiology: The Essentials offers a concise overview of the diseased states of the lung, emphasizing structure and function. The Eighth Edition is updated to include new information on asthma therapies, new radiographs and micrographs, extended sections on infections and cancer, more thorough explanations for review questions, and a new summary appendix of equations with sample calculations.

© 2016 BrightSurf.com